Search

Grotz, Sophia, Jessica Schäfer, Kirsten Wunderlich, Zdenka Ellederova, Hannah Auch, Andrea Bähr, Petra Runa-Vochozkova, et al. 2022. “Early Disruption of Photoreceptor Cell Architecture and Loss of Vision in a Humanized Pig Model of Usher Syndromes”. EMBO Mol Med 14 (4): e14817.

Elhusseiny, Abdelrahman, and Hajirah Saeed. 2022. “Corneal Opacification in Sanjad-Sakati Syndrome”. Am J Ophthalmol Case Rep 26: 101503.

Hunter, David. 2022. “Enhancing Comparison of Different Vision Screening Approaches”. J AAPOS.

White, Emily, and Leah Walsh. 2022. “The Impact of Occlusion Therapy and Predictors on Amblyopia Dose-Response Relationship”. Strabismus 30 (2): 78-89.

Müller, Rodrigo, Farshad Abedi, Andrea Cruzat, Deborah Witkin, Neda Baniasadi, Bernardo Cavalcanti, Arsia Jamali, et al. 2015. “Degeneration and Regeneration of Subbasal Corneal Nerves After Infectious Keratitis: A Longitudinal InVivo Confocal Microscopy Study.”. Ophthalmology 122 (11): 2200-9.

Guevarra, Ma Carmela, Michelle Ann Eala, Edward Christopher Dee, Gary John Mercado, and Edward Ryan Collantes. 2022. “Looking through the Scope: Retinoblastoma in the Philippines”. Eye (Lond) 36 (12): 2356-57.

Li, Sanming, Liying Tang, Jing Zhou, Sonia Anchouche, Dian Li, Yiran Yang, Zhaolin Liu, et al. 2022. “Sleep Deprivation Induces Corneal Epithelial Progenitor Cell Over-Expansion through Disruption of Redox Homeostasis in the Tear Film”. Stem Cell Reports 17 (5): 1105-19.

Elhusseiny, Abdelrahman, Aisha Traish, Hajirah Saeed, and Iason Mantagos. 2022. “Topical Cenegermin 0.002% for Pediatric Neurotrophic Keratopathy”. Eur J Ophthalmol 32 (6): 3420-24.

Hall, Nathan, Enchi Chang, Sandy Samuel, Sanchay Gupta, Emma Klug, Tobias Elze, Alice Lorch, Joan Miller, and David Sola-Del Valle. 2022. “Risk Factors for Glaucoma Drainage Device Revision or Removal Using the IRIS Registry”. Am J Ophthalmol.

Douglas, Vivian Paraskevi, Konstantinos Aa Douglas, Demetrios Vavvas, Joan Miller, and John Miller. 2022. “Short- and Long-Term Visual Outcomes in Patients Receiving Intravitreal Injections: The Impact of the Coronavirus 2019 Disease (COVID-19)-Related Lockdown”. J Clin Med 11 (8).